APPLICATION
ANDA065050
TYPE
ANDA
ORIGINAL APPROVAL
2000-09-11
LATEST ACTION
2004-11-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CEFOXITINPrescription
CEFOXITIN SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2004-11-02Labeling · Supplement 3AP
2003-12-19Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.